Torrent Pharma Ups Stake in JB Chemicals with ₹6.2 Bn Deal—Strengthens Strategic Hold

Torrent Pharmaceuticals Ltd has agreed to acquire an additional 2.41% equity stake in JB Chemicals & Pharmaceuticals Ltd for approximately ₹6.2 billion, reinforcing its strategic interest in the mid-cap pharma player. The transaction, executed via block deals on the open market, takes Torrent’s total holding in JB Chemicals to over 35%, edging closer to a potential controlling interest.

 

This move follows Torrent’s earlier acquisitions in JB Chemicals, signaling a long-term consolidation strategy in the domestic formulations and specialty therapeutics space. JB Chemicals, known for brands like Metrogyl, Rantac, and Nicardia, has a strong presence in both India and emerging markets.

 

Analysts view the deal as a value-accretive move, given JB’s robust EBITDA margins and expanding international footprint. The acquisition also aligns with Torrent’s broader M&A playbook, which includes past takeovers like Elder Pharma and Unichem’s domestic business.

 

Key Highlights:

Source: Economic Times – Torrent Pharma Stake Buy in JB Chemicals